Cargando…
Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia
INTRODUCTION: Our study was designed to investigate the safety and efficacy of combined autologous bone marrow mononuclear cell (MNC) and gene therapy in comparison to conventional drug therapy in patients with critical limb ischemia (CLI). MATERIAL AND METHODS: Thirty-two patients with CLI persisti...
Autores principales: | Skóra, Jan, Pupka, Artur, Janczak, Dariusz, Barć, Piotr, Dawiskiba, Tomasz, Korta, Krzysztof, Baczyńska, Dagmara, Mastalerz-Migas, Agnieszka, Garcarek, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424239/ https://www.ncbi.nlm.nih.gov/pubmed/25995748 http://dx.doi.org/10.5114/aoms.2013.39935 |
Ejemplares similares
-
Complementary Gene Therapy after Revascularization with the Saphenous Vein in Diabetic Foot Syndrome
por: Kupczyńska, Diana, et al.
Publicado: (2023) -
Two-Stage Gene Therapy (VEGF, HGF and ANG1 Plasmids) as Adjunctive Therapy in the Treatment of Critical Lower Limb Ischemia in Diabetic Foot Syndrome
por: Barć, Piotr, et al.
Publicado: (2022) -
Double VEGF/HGF Gene Therapy in Critical Limb Ischemia Complicated by Diabetes Mellitus
por: Barć, Piotr, et al.
Publicado: (2020) -
Prognostic value of tissue factor in patients with abdominal aortic and iliac arterial aneurysms – preliminary study
por: Skóra, Jan, et al.
Publicado: (2013) -
Safe doubling of ventilator capacity: a last resort proposal for last resorts
por: Chase, J. Geoffrey, et al.
Publicado: (2020)